Skip to main content
EJNMMI Research
Fig. 6 | EJNMMI Research

Fig. 6

From: Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

Fig. 6

Alpha-camera images for the spleen, thymus, kidney, and tumor following i.v. administration of 225Ac-DOTA-anti-PD-L1-BC (67 kBq, 3 mg/kg). The scale is normalized for each tissue so that the average intensity across each row is set to 1. A 72-h kidney image and 144-h images for all other organs could not be obtained due to low counts

Back to article page